Trial Profile
Safety, tolerability and multiple dose pharmacokinetics of an immediate release tablet formulation of F901318 in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 May 2017
Price :
$35
*
At a glance
- Drugs Olorofim (Primary)
- Indications Aspergillosis
- Focus Adverse reactions; Pharmacokinetics
- 13 May 2017 New trial record
- 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases